FDA Inspection 1059965 — Institute for Reproductive Medicine and Science at Saint Barnabas, P.A.
The FDA completed an inspection of Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. on July 19, 2018 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 19, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Livingston, NJ (United States)